SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-031185
Filing Date
2024-02-12
Accepted
2024-02-12 08:42:03
Documents
19
Period of Report
2024-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d791540d8k.htm   iXBRL 8-K 52608
2 EX-2.1 d791540dex21.htm EX-2.1 463067
3 EX-3.1 d791540dex31.htm EX-3.1 4958
4 EX-99.1 d791540dex991.htm EX-99.1 22849
8 GRAPHIC g791540dsp01.jpg GRAPHIC 4021
9 GRAPHIC g791540dsp01a.jpg GRAPHIC 5298
  Complete submission text file 0001193125-24-031185.txt   819906

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20240211.xsd EX-101.SCH 2850
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20240211_lab.xml EX-101.LAB 18739
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20240211_pre.xml EX-101.PRE 11707
20 EXTRACTED XBRL INSTANCE DOCUMENT d791540d8k_htm.xml XML 3835
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 24617523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)